1. Andriesen MP, Barendsen GJ, Wouda AA, de Pater L (1989) Changes of walking distance in patients with intermittent claudication during six months intensive physical training. VASA 18:63
2. Balzer K, Rogatti W, Rüttgerodt K (1989) Efficacy and tolerability of intra-arterial and intravenous prostaglandin Ex infusions in occlusive arterial disease stage III/IV. VASA (Suppl 28):31
3. Belch JJF McArdle B, Pollock JG, Forbes CD, Mx Kay A, Leiberman P, Lowe GDO, Prentice CRM (1983) Epoprostenol (prostacyclin) and severe arterial disease. A double blind trail. Lancet 1:315
4. Bergström S, Carlson LA, Weeks JR (1968) The prostaglandins: a familiy of biologically active lipids. Pharmacol Rev. 20:1
5. Brock FE, Abri O, Baitsch et al. (1990) Iloprost in der Behandlung ischämischer Gewebsläsionen bei Diabetikern. Schweiz. Med. Wochenschr. 120:1477–1482